Research articles
Since 2019, ADRIA has built a research-use-only article archive covering peptide literature, analytical documentation, storage, laboratory workflow, and evidence limits. The archive is organized by topic so researchers can move from source review to COA, calculator, and catalogue context quickly.
A compliance-safe metabolic research article covering GH-axis literature, lipid and glucose markers, obesity-model evidence, and why consumer claims are inappropriate.
Read more
A cautious rewrite of the lifespan article, focused on peptide bioregulation papers, animal-model limits, biomarkers, telomerase literature, and why 110-year claims need restraint.
Read more
A research-only Ipamorelin article focused on selective GH secretagogue literature, comparative GHRP studies, hormone-panel endpoints, and documentation.
Read more
A conservative AOD-9604 article focused on GH fragment 176-191, lipid metabolism models, PubChem identity, and why consumer claims are not appropriate.
Read more
A cleaner comparison of GHRP-2 and GHRP-6 research, focused on GHS-R signaling, GH-release assays, cAMP findings, and endpoint differences.
Read more
A research-only Hexarelin article covering GH secretagogue activity, hormone-panel observations, repeated-study observations, and evidence limits.
Read more
A second Hexarelin article reframed around mechanism mapping: GHS-R activity, pituitary signaling, GH-axis markers, and why strong claims should be avoided.
Read more
A research-use-only GHRP group article that compares classes by study endpoint, receptor context, and hormone-panel findings instead of strongest-to-weakest rankings.
Read more
A research-use-only BPC-157 literature note focused on tendon explant research, fibroblast migration assays, oxidative-stress markers, and FAK-paxillin pathway limits.
Read moreResearch-use access
Adria Peptides products are supplied strictly for lawful research, laboratory, analytical, educational, or R&D purposes where permitted by applicable law.